Results 81 to 90 of about 1,474 (179)

Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease. [PDF]

RSC Adv, 2023
Naseem S, Temirak A, Imran A, Jalil S, Fatima S, Taslimi P, Iqbal J, Tasleem M, Tahir MN, Shafiq Z.   +9 more
europepmc   +1 more source

Synthesis of 2-aryl-5-(arylsulfonyl)-1,3,4-oxadiazoles as potent antibacterial and antioxidant agents. [PDF]

Turk J Chem, 2022
Murthy BSN, Talari S, Kola AE, Chalapaka B.   +3 more
europepmc   +1 more source

Copper-Catalyzed One-Pot Synthesis of 2,5-Disubstituted 1,3,4-Oxadiazoles from Arylacetic Acids and Hydrazides via Dual Oxidation. [PDF]

ACS Omega, 2022
Lekkala C, Bodala V, Yettula K, Karasala BK, Podugu RL, Vidavalur S.   +5 more
europepmc   +1 more source

2,5-Bis(2,2,2-trifluoroethoxy)phenyl-tethered 1,3,4-Oxadiazoles Derivatives: Synthesis, In Silico Studies, and Biological Assessment as Potential Candidates for Anti-Cancer and Anti-Diabetic Agent. [PDF]

Molecules, 2022
Shankara SD, Isloor AM, Kudva AK, Raghu SV, Jayaswamy PK, Venugopal PP, Shetty P, Chakraborty D.   +7 more
europepmc   +1 more source

Iodine-mediated 2,5-di(aryl/heteroaryl)-1,3,4-oxadiazoles: synthesis, and <i>in vitro</i> and <i>in silico</i> studies of anticancer and antifungal properties. [PDF]

RSC Adv
Ramesha T, Shenoy TN, Subba Reddy UV, Ega JK, Gogula SS, Swathi B, Burgula S, Reddy PM, Abdul Salam AA.   +8 more
europepmc   +1 more source

New 5-(pyridin-3-yl)-1,3,4-oxadiazoles derivatives as VEGFR2 inhibitors: <i>in silico</i> study, synthesis, and cytotoxicity evaluation. [PDF]

Res Pharm Sci
Abdulhussein AN, Oleiwi MA.
europepmc   +1 more source

Tri-1,3,4-Oxadiazoles Modified with Nitroimine: Balancing Energy, Sensitivity, and Thermal Stability. [PDF]

Molecules
Chen F, Yu Q, Li L, Peng K, Zhu C, Yi W.
europepmc   +1 more source

Additive-free photo-mediated oxidative cyclization of pyridinium acylhydrazones to 1,3,4-oxadiazoles: solid-state conversion in a microporous organic polymer and supramolecular energy-level engineering. [PDF]

RSC Adv, 2021
Kim KS, Chung YK, Kim H, Ha CY, Huh J, Song C.   +5 more
europepmc   +1 more source

Rational design of naphtho[2,3-<i>d</i>]imidazole-4,9-dione-linked 1,3,4-oxadiazoles as α-amylase inhibitors supported by QSAR, docking, molecular dynamics, and ADME approaches. [PDF]

RSC Adv
Devi M, Kumar P, Singh R, Sindhu J, Kumar A, Lal S, Singh D, Kumar H.   +7 more
europepmc   +1 more source

Effect of 1,3,4-oxadiazoles on expression of biofilm-associated bap gene in clinical isolates of multidrug-resistant Acinetobacter baumannii. [PDF]

Sci Rep
Rahimbakhsh A, Seyfahmadi M, Souldozi A, Hakimelahi R, Alikhani MY, Kafilzadeh F.   +5 more
europepmc   +1 more source